Skip to contentB
Bio Essence Corp
B
BIOEBio Essence Corp Q1 2026 · 10-Q
Revenue$500.54K$500.54K+2,155.8% vs Q1 2025 Net Income$205.37K$205.37KN/M vs Q1 2025 EPS Diluted$0.00$0.00N/M vs Q1 2025 Gross Profit$319,353+1,451.2% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Bio Essence Corp · CIK 1723059 · Engraved from SEC EDGAR
Operating Cash Flow-$411,970N/M Margins · derivedGross margin63.8%−29.0 pt vs Q1 2025
Operating margin43.1%+967.4 pt vs Q1 2025
Net margin41.0%+968.3 pt vs Q1 2025
ended Mar 31, 2026 · filed May 15, 2026 · 45 d after period end